BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11118345)

  • 1. The BRCT regions of tumor suppressor BRCA1 and of XRCC1 show DNA end binding activity with a multimerizing feature.
    Yamane K; Katayama E; Tsuruo T
    Biochem Biophys Res Commun; 2000 Dec; 279(2):678-84. PubMed ID: 11118345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA.
    Yamane K; Tsuruo T
    Oncogene; 1999 Sep; 18(37):5194-203. PubMed ID: 10498869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma susceptibility protein, Rb, possesses multiple BRCT-Ws, BRCA1 carboxyl-terminus-related W regions with DNA break-binding activity.
    Yamane K; Katayama E; Sugasawa K; Tsuruo T
    Oncogene; 2000 Apr; 19(16):1982-91. PubMed ID: 10803459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 contains a DNA break-binding motif similar to the functional part of BRCT-related region of Rb.
    Yamane K; Katayama E; Tsuruo T
    Oncogene; 2001 May; 20(23):2859-67. PubMed ID: 11420698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BRCT domain is a phospho-protein binding domain.
    Yu X; Chini CC; He M; Mer G; Chen J
    Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Au WW; Henderson BR
    Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
    Zhang X; Moréra S; Bates PA; Whitehead PC; Coffer AI; Hainbucher K; Nash RA; Sternberg MJ; Lindahl T; Freemont PS
    EMBO J; 1998 Nov; 17(21):6404-11. PubMed ID: 9799248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification, characterization, and crystallization of the distal BRCT domain of the human XRCC1 DNA repair protein.
    Thornton K; Forstner M; Shen MR; West MG; Rupp B; Thelen MP
    Protein Expr Purif; 1999 Jul; 16(2):236-42. PubMed ID: 10419820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the BRCA1 BRCT interaction with the proteins ATRIP and BAAT1.
    Liu X; Ladias JA
    Biochemistry; 2013 Oct; 52(43):7618-27. PubMed ID: 24073851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.
    Bork P; Hofmann K; Bucher P; Neuwald AF; Altschul SF; Koonin EV
    FASEB J; 1997 Jan; 11(1):68-76. PubMed ID: 9034168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS; Lee MS; Hau DD; Glover JN
    Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III.
    Dulic A; Bates PA; Zhang X; Martin SR; Freemont PS; Lindahl T; Barnes DE
    Biochemistry; 2001 May; 40(20):5906-13. PubMed ID: 11352725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains.
    Wright RH; Dornan ES; Donaldson MM; Morgan IM
    Biochem J; 2006 Dec; 400(3):573-82. PubMed ID: 16984230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of a BRCT domain in the interaction of DNA ligase III-alpha with the DNA repair protein XRCC1.
    Taylor RM; Wickstead B; Cronin S; Caldecott KW
    Curr Biol; 1998 Jul; 8(15):877-80. PubMed ID: 9705932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
    Williams RS; Green R; Glover JN
    Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the structures and peptide binding specificities of the BRCT domains of MDC1 and BRCA1.
    Campbell SJ; Edwards RA; Glover JN
    Structure; 2010 Feb; 18(2):167-76. PubMed ID: 20159462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
    Gough CA; Gojobori T; Imanishi T
    Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.
    Gaiser OJ; Ball LJ; Schmieder P; Leitner D; Strauss H; Wahl M; Kühne R; Oschkinat H; Heinemann U
    Biochemistry; 2004 Dec; 43(51):15983-95. PubMed ID: 15609993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1.
    Lokesh GL; Rachamallu A; Kumar GD; Natarajan A
    Anal Biochem; 2006 May; 352(1):135-41. PubMed ID: 16500609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure and backbone dynamics of the human DNA ligase IIIalpha BRCT domain.
    Krishnan VV; Thornton KH; Thelen MP; Cosman M
    Biochemistry; 2001 Nov; 40(44):13158-66. PubMed ID: 11683624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.